Buscar
Resultados de la búsqueda
Select an image to start the slideshow
Implications of Vertical Integration in the Oncology Market
1 of 16
Engineering Armored CAR T Cells to Secrete Functional VIPR Antagonist
2 of 16
Real World Outcomes of Melanoma Brain Metastases Treated with Immunotherapy with or without Stereotactic Radiosurgery
3 of 16
Tumor Membrane Vesicles as a Personalized Vaccine Immunotherapy Platform for Cancer
4 of 16
Differentiation of CD8 T cells during chronic viral infection
5 of 16
Intertumoral and Intratumoral Heterogeneity of Cancer: Types, Causes, Detection, and Clinical Implications
6 of 16
Dynamic Immune and Stromal Modulation by Therapeutic Targeting of IL-6 in Pancreatic Cancer
7 of 16
Inhibiting VIP Receptor Signaling Promotes T Cell Mediated Immune Response in Murine Melanoma Models
8 of 16
Developing novel cellular and gene therapies for pediatric malignancies
9 of 16
The utilization of concurrent immunotherapy and its impact on overall survival among late-stage melanoma patients treated by surgery: a query on the National Cancer Database
10 of 16
Induction of anti-tumor immunity by vaccine immunotherapy in murine lung cancer models
11 of 16
Development of a Tumor Membrane-based Vaccine for Breast Cancer, Studied as a Monotherapy and in Combination with Immune Checkpoint Blockade Antibodies
12 of 16
Targeting TIM-3 to reverse immune exhaustion during chronic viral infection
13 of 16
Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses
14 of 16
Assessing Predictors of Outcomes of Guidelines-Concordant Treatment in Women with Early Stage Breast Cancer
15 of 16
Antagonism of the vasoactive intestinal peptide and PI3K δ signaling pathways in T cell-based therapies for leukemia and lymphoma
16 of 16